Entia Biosciences, Inc.
Entia Biosciences, Inc. (ERGO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ERGO · as of Jun 9, 2026
Key Statistics
Explore Entia Biosciences, Inc. Data
ergo stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
ergo competitorsERGO
AVXT
BNGI
BTAX
BTTX
DNAGStock Performance
Full HistoryAbout Entia Biosciences, Inc.
Entia Biosciences, Inc. (ERGO) is a U.S.-based company primarily engaged in the development, manufacturing, and distribution of dietary supplements, nutraceuticals, and medical food products. The comp…
what is entia biosciences, inc. · ergo stock overview · entia biosciences, inc. company profile · who is entia biosciences, inc. ceo · ergo OTC · entia biosciences, inc. headquarters · entia biosciences, inc. business segments
About Stock Overview & Key Data
Entia Biosciences, Inc. (ERGO) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 18, 2008. As of the latest trading session, ERGO stock price is $0.00, with a market capitalization of $20,197. The stock has returned +500.00% over the past 12 months and +100.00% year-to-date.
In fiscal year 2016, Entia Biosciences, Inc. reported revenue of $265466.00. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Entia Biosciences, Inc. (ERGO) stock price is $0.00. The stock is traded on OTC under the ticker symbol ERGO. The 52-week range is $0.00 – $0.04.